Viridian Therapeutics Stock Forecast

Stock Price Forecast

The 12 analysts with 12-month price forecasts for Viridian Therapeutics stock have an average target of 41.17, with a low estimate of 29 and a high estimate of 61. The average target predicts an increase of 45.89% from the current stock price of 28.22.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$29	$41.17	$42	$61
Change	+2.76%	+45.89%	+48.83%	+116.16%

Analyst Ratings

The average analyst rating for Viridian Therapeutics stock from 13 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Oct '25	Nov '25	Dec '25	Jan '26	Feb '26	Mar '26
Strong Buy	4	6	5	6	6	6
Buy	5	4	6	6	6	6
Hold	1	1	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	10	11	12	13	13	13

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Lisa Walter RBC Capital	RBC Capital	Buy Maintains $45 → $42	Buy	Maintains	$45 → $42	+48.83%	Feb 27, 2026
Serge Belanger Needham	Needham	Strong Buy Reiterates $42	Strong Buy	Reiterates	$42	+48.83%	Feb 4, 2026
Derek Archila Wells Fargo	Wells Fargo	Hold Maintains $26 → $29	Hold	Maintains	$26 → $29	+2.76%	Feb 3, 2026
Gregory Renza Truist Securities	Truist Securities	Strong Buy Maintains $41 → $40	Strong Buy	Maintains	$41 → $40	+41.74%	Jan 8, 2026
Michael Yee UBS	UBS	Strong Buy Initiates $50	Strong Buy	Initiates	$50	+77.18%	Jan 7, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

80.70M

from 70.85M

13.90%

from 70.85M

Revenue Next Year

310.33M

from 80.70M

284.55%

from 80.70M

EPS This Year

-3.76

from -3.32

EPS Next Year

-2.05

from -3.76

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	2.96M	1.77M	314.00K	302.00K	70.85M	80.70M	310.33M
Revenue Growth	182.19%	-40.20%	-82.28%	-3.82%	23,359.93%	13.90%	284.55%
EPS	-6.66	-2.71	-3.91	-3.07	-3.32	-3.76	-2.05
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	18	15

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	217.7M	523.8M
Avg	80.7M	310.3M
Low	14.8M	142.1M

Revenue Growth

Revenue Growth	2026	2027
High	207.2%	549.1%
Avg	13.9%	284.6%
Low	-79.1%	76.0%

EPS Forecast

EPS	2026	2027
High	-2.45	-0.54
Avg	-3.76	-2.05
Low	-4.64	-3.25

EPS Growth

EPS Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.